Technical Analysis for TLGT - Teligent, Inc.
|Grade||Last Price||% Change||Price Change|
TLGT closed down 2.25 percent on Friday, January 18, 2019, on 43 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical TLGT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||1,2,3 Pullback Bullish||Bullish Swing Setup||0.00%|
|Jan 18||Narrow Range Bar||Range Contraction||0.00%|
|Jan 18||Weak + Overbought||Other||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 17||Narrow Range Bar||Range Contraction||-2.25%|
|Jan 17||Weak + Overbought||Other||-2.25%|
|Jan 17||Wide Bands||Range Expansion||-2.25%|
|Jan 17||Overbought Stochastic||Strength||-2.25%|
|Jan 16||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets topical formulations in the United States. It sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms under IGI label. The company also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter (OTC) and cosmetic markets. Its products are used in various applications from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, the company offers pharmaceutical contract services comprising formulating, testing, and/or manufacturing prescription drugs and medical devices; and contract development services consisting of developing topical formulations. It has a license agreement with Novavax, Inc. to utilize the Novasome lipid vesicle encapsulation and certain other technologies for applications in animal pharmaceuticals, biologicals, and other animal health products; foods, food applications, nutrients, and flavorings; cosmetics, consumer products, and dermatological OTC and prescription products; fragrances; and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals, and other specialty chemicals. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more TLGT news...
|52 Week High||4.52|
|52 Week Low||1.13|
|200-Day Moving Average||3.1458|
|50-Day Moving Average||1.9371|
|20-Day Moving Average||1.4845|
|10-Day Moving Average||1.642|
|Average True Range||0.1617|
|Chandelier Exit (Long, 3 ATRs )||1.3749|
|Chandelier Exit (Short, 3 ATRs )||1.6151|
|Upper Bollinger Band||1.8721|
|Lower Bollinger Band||1.0969|
|Percent B (%b)||0.83|
|MACD Signal Line||-0.1135|
|Market Cap||92.9 Million|
|Num Shares||53.4 Million|
|Price-to-Earnings (P/E) Ratio||-10.88|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.86|
|Resistance 3 (R3)||1.87||1.83||1.84|
|Resistance 2 (R2)||1.83||1.80||1.83||1.83|
|Resistance 1 (R1)||1.79||1.78||1.77||1.78||1.83|
|Support 1 (S1)||1.71||1.72||1.69||1.70||1.65|
|Support 2 (S2)||1.67||1.70||1.67||1.65|
|Support 3 (S3)||1.63||1.67||1.64|
|Support 4 (S4)||1.62|